CGN Stock Price, Chart, Stats & News

Cognetivity Neurosciences Ltd.
Save
Cognetivity Neurosciences Ltd. (CGN) does not currently pay a dividend.
895,886
Market cap
–
Current P/E
–
Forward P/E
CGN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Healthcare Information Services
Industry
Cognetivity Neurosciences Ltd. operates as a healthcare firm, specializing in the development of an integrated cognitive assessment platform. This advanced testing system, applicable across medical, commercial, and consumer environments, is designed to identify the earliest indicators of cognitive impairment by evaluating the performance of broad brain regions, thereby aiding in the diagnosis of dementia. The company also offers OptiMind, a dedicated wellness application.
Similar securities
Based on sector and market capitalization
Report issue











